PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Canada

Centre Hospitalier de l'université de Montréal, Montreal, Quebec